LifeMD Inc (LFMD)
5.98
-1.02
(-14.51%)
USD |
NASDAQ |
Nov 14, 16:00
5.81
-0.17
(-2.84%)
After-Hours: 20:00
LifeMD Enterprise Value: 285.85M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 285.85M |
| November 12, 2024 | 292.96M |
| November 11, 2024 | 290.37M |
| November 08, 2024 | 236.54M |
| November 07, 2024 | 205.53M |
| November 06, 2024 | 202.51M |
| November 05, 2024 | 176.67M |
| November 04, 2024 | 173.23M |
| November 01, 2024 | 170.64M |
| October 31, 2024 | 160.31M |
| October 30, 2024 | 163.32M |
| October 29, 2024 | 170.21M |
| October 28, 2024 | 173.87M |
| October 25, 2024 | 169.35M |
| October 24, 2024 | 167.63M |
| October 23, 2024 | 173.66M |
| October 22, 2024 | 174.95M |
| October 21, 2024 | 177.96M |
| October 18, 2024 | 186.15M |
| October 17, 2024 | 181.84M |
| October 16, 2024 | 189.59M |
| October 15, 2024 | 192.18M |
| October 14, 2024 | 184.43M |
| October 11, 2024 | 173.23M |
| October 10, 2024 | 165.91M |
| Date | Value |
|---|---|
| October 09, 2024 | 176.24M |
| October 08, 2024 | 185.72M |
| October 07, 2024 | 189.59M |
| October 04, 2024 | 192.61M |
| October 03, 2024 | 186.15M |
| October 02, 2024 | 206.82M |
| October 01, 2024 | 202.94M |
| September 30, 2024 | 210.27M |
| September 27, 2024 | 208.97M |
| September 26, 2024 | 208.54M |
| September 25, 2024 | 206.82M |
| September 24, 2024 | 229.22M |
| September 23, 2024 | 205.10M |
| September 20, 2024 | 196.05M |
| September 19, 2024 | 211.99M |
| September 18, 2024 | 210.27M |
| September 17, 2024 | 208.54M |
| September 16, 2024 | 205.53M |
| September 13, 2024 | 211.56M |
| September 12, 2024 | 209.84M |
| September 11, 2024 | 211.99M |
| September 10, 2024 | 198.21M |
| September 09, 2024 | 191.32M |
| September 06, 2024 | 190.89M |
| September 05, 2024 | 197.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.919M
Minimum
Mar 12 2020
723.82M
Maximum
Feb 17 2021
156.48M
Average
127.49M
Median
Enterprise Value Benchmarks
| Veradigm Inc | -- |
| TruBridge Inc | 408.40M |
| Streamline Health Solutions Inc | 18.98M |
| LENZ Therapeutics Inc | 783.65M |
| Oruka Therapeutics Inc | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.876M |
| Revenue (Quarterly) | 50.66M |
| Total Expenses (Quarterly) | 56.97M |
| EPS Diluted (Quarterly) | -0.19 |
| Gross Profit Margin (Quarterly) | 90.08% |
| Profit Margin (Quarterly) | -13.57% |
| Earnings Yield | -11.71% |
| Normalized Earnings Yield | -11.71 |